Research output per year
Research output per year
Personal profile
Education
- 2018.09-2024.01 Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2001.09-2008.06 M.D., School of Medicine, Kaohsiung Medical University
Experience
- 2024.11- Assistant professor, School of Respiratory Therapy, Taipei Medical University
- 2024.08- Acting Director, Division of Thoracic Medicine, Department of Internal Medicine, Taipei Medical University Hospital
- 2015.01- Attending physician, Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital
- 2012.07-2014.12 Chief Resident, Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital
- 2009.07-2012.06 Resident Physician, Department of Internal Medicine, Taipei Medical University Hospital
Research Interests
- Lung cancer
- COPD
- Asthma
- Interstitial lung disease
- pleural effusion
Fingerprint
Dive into the research topics where Kai-Ling Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression
Ho, C. B., Tsai, J. T., Chen, C. Y., Shiah, H. S., Chen, H. Y., Ting, L. L., Kuo, C. C., Lai, I. C., Lai, H. Y., Chung, C. L., Lee, K. L., Tzeng, H. E., Lee, K. H., Lee, H. L., Chen, S. W. & Chiou, J. F., May 2023, In: Diagnostics. 13, 9, 1597.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
IL-17A induces EGFR-targeted therapy resistance via enhancing EGFR activation in lung cancer
Lee, K. L., Chung, C.-L. & Chien, M.-H., Oct 2023.Research output: Contribution to conference › Paper › peer-review
-
Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer
Lee, K.-L., Lai, T. C., Lee, W.-J., Chen, Y.-C., Ho, K.-H., Hung, W.-Y., Yang, Y.-C., Chan, M.-H., Hsieh, F.-K., Chung, C.-L., Chang, J.-H. & Chien, M.-H., Jun 22 2023, In: Cancers. 15, 13Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Toll-like Receptor 2 Mediates VEGF Overexpression and Mesothelial Hyperpermeability in Tuberculous Pleural Effusion
Chen, W. L., Lee, K. L., Lai, K. S., Tsai, J. H., Hsiao, S. H. & Chung, C. L., Feb 2023, In: International journal of molecular sciences. 24, 3, 2846.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Potential impacts of interleukin-17a promoter polymorphisms on the egfr mutation status and progression of non-small cell lung cancer in Taiwan
Lee, K. L., Lai, T. C., Wang, Y. C., Shih, P. C., Yang, Y. C., Tsao, T. C. Y., Liu, T. C., Wen, Y. C., Chang, L. C., Yang, S. F. & Chien, M. H., Mar 2021, In: Genes. 12, 3, 427.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus)